Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function

Molecular and Cellular Biology

Volumn 22, Issue 10, 2002, Pages 3373-3388

  Fu, Maofu ^a   Wang, Chenguang ^a   Wang, Jian ^a   Zhang, Xueping ^a   Sakamaki, Toshiyuki ^a   Yeung, Y G ^a   Chang, Chawnshang ^a   Hopp, Torsten ^a   Fuqua, Suzanne A W ^a   Jaffray, Ellis ^a   Hay, Ron T ^a   Palvimo, Jorma J ^a   Jänne, Olli A ^a   Pestell, Richard G ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ACETYLATION; APOPTOSIS; ARTICLE; BINDING SITE; CANCER SURVIVAL; CELL SURVIVAL; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME BINDING; ENZYME REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; LIGAND BINDING; POINT MUTATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN MODIFICATION; PROTEIN MOTIF; REPORTER GENE; REPRESSOR GENE; SEX DIFFERENTIATION;

ACETYLATION; AMINO ACID MOTIFS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; DIHYDROTESTOSTERONE; DNA-BINDING PROTEINS; ENZYME INHIBITORS; GENES, REPORTER; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; MALE; MAP KINASE KINASE KINASE 1; MEMBRANE GLYCOPROTEINS; POINT MUTATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ANDROGEN; SMAD3 PROTEIN; SUMO-1 PROTEIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18344371150     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.10.3373-3388.2002     Document Type: Article

References (95)

1. CREB-binding protein in androgen receptor-mediated signaling
2. Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer
3. Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism
4. Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis
5. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription
6. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
7. Tumor necrosis factor-alpha activation of the c-Jun N-terminal kinase pathway in human neutrophils. Integrin involvement in a pathway leading from cytoplasmic tyrosine kinases apoptosis
8. New androgen response elements in the murine pem promoter mediate selective transactivation
9. Interaction of steroid hormone receptors with the transcription initiation complex
10. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice
11. Androgens arc not a direct requirement for the proliferation of human prostatic epithelium in vitro
12. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1
13. Transforming growth factor β1 recruits histone deacetylase I to a p130 repressor complex in transgenic mice in vivo
14. Regulation of activity of the transcription factor GATA-1 by acetylation
15. Tip60 is a nuclear hormone receptor coactivator
16. Stat3 as an oncogene
17. Co-repressors 2000
18. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase
19. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein
20. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: Implications for nuclear localisation
21. BRCA1 inhibition of estrogen receptor signaling in transfected cells
22. CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1
23. p300 and P/CAF acetylate the androgen receptor at sites governing hormone-dependent transactivation
24. Prostate cancer: Emerging concepts. Part II
25. Differential involvement of MEK kinase 1 (MEKK1) in the induction of apoptosis in response to microtubule-targeted drugs versus DNA damaging agents
26. p300 and CBP: Partners for life and death
27. The coregulator exchange in transcriptional functions of nuclear receptors
28. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
29. SMAD3 represses androgen receptor-mediated transcription
30. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
31. Nuclear receptor coactivators and corepressors
32. Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors
33. CREB-binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites
34. Interaction between the amino- and earboxyl-terminal regions of the at androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators
35. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis
36. Structure and function of a human TAFII250 double bromodomain module
37. NF-κB and cell-cycle regulation: The cyclin connection
38. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor
39. Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element
40. From transforming growth factor-b signaling to androgen action: Identification of Smad3 as an androgen receptor coregulator in prostate cancer cells
41. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression
42. HIV Tat transcriptional activity is regulated by acetylation
43. Sin meets NuRD and other tails of repression
44. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability
45. Acetylation: A regulatory modification to rival phosphorylation
46. Sounding the alarm: Protein kinase cascades activated by stress and inflammation
47. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway
48. Kipl mediates apoptosis in endothelial cells through activation of cdk2: Role of a caspase cascade
49. Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo
50. Role of the histone deacetylase complex in acute promyelocytic leukaemia
51. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage
52. Androgen induction of cyclin-dependent kinase inhibitor p21 gene: Role of androgen receptor and transcription factor Spl complex
53. Rb interacts with histone deacetylase to repress transcription
54. The acetyltransferase activity of CBP stimulates transcription
55. Structural evidence for ligand specificity in the binding domain of the human androgen receptor
56. Nuclear receptor co-regulators: Cellular and molecular biology
57. c-Jun and p53 activity is modulated by SUMO-1 modification
58. TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2
59. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A and histone deacetylase
60. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels
61. The transcriptional coactivators p300 and CBP are histone acetyltransferases
62. Mutual transcriptional interference between RelA and androgen receptor
63. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
64. Competitive recruitment of CBP and Rb-HDAC regulates UBF acetylation and ribosomal transcription
65. Activator protein-2 mediates transcriptional activation of the CYP11A1 gene by interaction with Spl rather than binding to DNA
66. Molecular determinants of nuclear receptor-corepressor interaction
67. Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase
68. Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription
69. Coregulator small nuclear RING finger protein (SNURF) enhances Spland steroid receptor-mediated transcription by different mechanisms
70. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)
71. The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor
72. Why is p53 acetylated?
73. Cyclin D1 governs androgen receptor function by ligand-dependent regulation of P/CAF
74. A consensus DNA-binding site for the androgen receptor
75. DNA damage activates p53 through a phosphorylation-acetylation cascade
76. Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP
77. Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors
78. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition
79. Characterization of two nuclear androgen receptors in Atlantic croaker: Comparison of their biochemical properties and binding specificities
80. Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium
81. Acetylation of histones and transcription-related factors
82. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9
83. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
84. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
85. The co-activator TIF2 contains three nuclear receptor binding motifs and mediates transactivation through CBP binding-dependent and-independent pathways
86. Direct acetylation of the estrogen receptor α hinge region by p300 regulates transactivation and hormone sensitivity
87. Histone acetylation and the cell-cycle in cancer
88. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Spl
89. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis
90. Novel substrate specificity of the histone acetyltransfcrase activity of HIV-1-Tat interactive protein Tip60
91. The nuclear hormone receptor coactivator SRC-I is a specific target of p300
92. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells
93. Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells
94. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells
95. Acetylation and modulation of erythroid Kruppel-like factor (EKLF) activity by interaction with histone acetyltransferases